MedRhythms, Inc. logo

MedRhythms, Inc.

Creating a world where everyone with neurologic injuries and diseases has access to the highest quality care.

51 employees · est. 2013 · Portland, United States

VS
Orna Therapeutics logo

Orna Therapeutics

Wholly Owned Subsidiary of Eli Lilly and Company

127 employees · est. 2019 · Watertown, United States

MedRhythms, Inc. is the older company (2013 vs 2019).

Side-by-Side Comparison

MedRhythms, Inc. Orna Therapeutics
Founded
2013 older 2019
Headquarters
Portland, United States Watertown, United States
Employees
51 127
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage
Series Unknown Corporate
Total Funding
$54.00M $2.72B
Funding Rounds
13 4
Services
Not tracked yet Development of circular RNA therapeutics, Implementation of in vivo CAR-T cell therapies, Tailored LNP delivery systems
Target Customers
Not tracked yet Patients with B cell-driven autoimmune diseases, Patients with oncology-related conditions, Biopharmaceutical partners
Taxonomy
Neurologic Music Therapy, Digital Medicine, Neuroscience, Medical Device, Innovation, Stroke, Multiple Sclerosis, Parkinson's Disease, Neurologic Interventions, Sensors, Brain Health, Neurotherapeutics, Mobility RNA Therapeutics, Circular RNA, ORNA Technology, Lipid Nanoparticle Delivery, In Vivo Therapies, Disease Treatment, Protein Expression, Therapeutic Development, Genetic Engineering, Drug Delivery Solutions, Novel Technology
Website
medrhythms.com ornatx.com
MedRhythms, Inc. logo

About MedRhythms, Inc.

MedRhythms is a pioneering biotechnology startup, founded in 2013, with a vision to transform brain health and mobility for individuals worldwide. Their slogan, "Creating a world where everyone with neurologic injuries and diseases has access to the highest quality care," encapsulates their mission....

Orna Therapeutics logo

About Orna Therapeutics

Orna Therapeutics, founded in 2019, is a cutting-edge biotechnology company that is redefining the scope of RNA therapeutics. Positioned as "Ahead of the Curve," the company is pioneering a novel circular RNA technology platform known as oRNA®, alongside innovative lipid nanoparticle (LNP) delivery...

We will tell you when either one moves

BounceWatch watches MedRhythms, Inc. and Orna Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at MedRhythms, Inc. and Orna Therapeutics — by email.

Frequently Asked Questions

MedRhythms, Inc. — Creating a world where everyone with neurologic injuries and diseases has access to the highest quality care.. Orna Therapeutics — Wholly Owned Subsidiary of Eli Lilly and Company. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
MedRhythms, Inc. has raised $54.00M while Orna Therapeutics has raised $2.72B.
MedRhythms, Inc. and Orna Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare MedRhythms, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at MedRhythms, Inc. on 12 Sep 2024, and Orna Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy